23-year-old biospecimen CRO marks milestone with expanded capabilities for translational research, biomarker discovery, companion diagnostic development, and liquid biopsy validation across oncology and autoimmune programs LOS ANGELES, June 2, 2026 /PRNewswire/ — MT Group, a specialty…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
